The role of PET scan in the preoperative management of oesophageal cancer

European Journal of Surgical Oncology

Volumn 30, Issue 9, 2004, Pages 942-947

  Liberale, Gabriel ^a,b   Van Laethem, J L ^a   Gay, F ^a   Goldman, S ^a   Nagy, N ^a   Coppens, E ^a   Gelin, M ^a   Nakadi, I El ^a  

^a ERASME HOSPITAL   (Belgium)

^b NONE   (Belgium)

Author keywords

18FDG PET; Accuracy; CT; EUS; Oesophageal cancer; Staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPROMIDE; SCOPOLAMINE BUTYL BROMIDE;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LOWER ESOPHAGUS SPHINCTER; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; ESOPHAGOGASTRIC JUNCTION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 7744233479     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.07.020     Document Type: Article

References (35)

1. Y. Refaely M.J. Krasna Multimodality therapy for esophageal cancer Surg Clin North Am 82 4 2002 729-746
2. I. El Nakadi J.J. Houben F. Gay J. Closset M. Gelin J.P. Lambilliotte Does esophagectomy cure a resectable esophageal cancer? World J Surg 17 6 1993 760-764
3. S.C. Chung R.C. Stuart A.K. Li Surgical therapy for squamous-cell carcinoma of the oesophagus Lancet 343 1994 521-524
4. B.J. Roth et al. Cancer: Principles and practice of oncology 4th ed 1993 Lippincott Philadelphia 717-817
5. L.L. Anderson T.E. Lad Autopsy findings in squamous-cell carcinoma of the esophagus Cancer 50 8 1982 1587-1590
6. A. Herskovic K. Martz M. al-Sarraf L. Leichman J. Brindle V. Vaitkevicius J. Cooper R. Byhardt L. Davis B. Emami Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus N Engl J Med 326 24 1992 1593-1598
7. H.S. Saunders N.T. Wolfman D.J. Ott Esophageal cancer Radiol Clin North Am 35 2 1997 281-294
8. P.A. Barbier P.J. Luder G. Schupfer C.D. Becker H.E. Wagner Quality of life and patterns of recurrence following transhiatal esophagectomy for cancer: Results of a prospective follow-up in 50 patients World J Surg 12 1988 270-276
9. K. Ziegler C. Sanft M. Zeitz et al. Evaluation of endosonography in TN staging of esophageal cancer Gut 32 1991 16-20
10. H.J. Dittler J.R. Siewert Role of endoscopic ultrasonography in esophageal carcinoma Endoscopy 25 1993 156-161
11. M.G. O'Brien E.F. Fitzgerald G. Lee et al. A prospective comparison of laparoscopy and imaging in the staging of esophagogastric cancer before surgery Am J Gastroenterol 90 1995 2191-2194
12. S. Yasuda et al. Application of whole body positron emission tomography in the imaging of esophageal cancer: Report of a case Surg Today 25 1995 261-264
13. J. Luketich R. Kim R. Landreneau et al. A comparaison of endoscopic ultrasound and minimally invasive surgical staging in esophageal cancer Am J Gastroenterol 91 1996 1892-1898
14. J. Luketich P. Schauer C. Meltzer et al. The role of positron emission tomography in staging esophageal cancer Ann Thorac Surg 64 1997 765-769
15. C.C. Meltzer J. Luketich D. Friedman M. Charron D. Strollo et al. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography Clin Nucl Med 25 11 2000 882-887
16. F.L. Flanagan F. Dehdashti B.A. Siegel et al. Staging of esophageal cancer with F-18-fluorodeoxyglucose positron emission tomography Am J Roentgenol 168 1997 417-424
17. M. Block G. Patterson R. Sundaresan et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography Ann Thorac Surg 64 1997 770-776
18. T. Fukunaga S. Okazumi Y. Koide et al. Evaluation of esophageal cancers using fluorine-18-fluorodeoxyglucose Pet J Nucl Med 39 1998 1002-1007
19. A. Kole J. Plukker O. Nieweg et al. Positron emission tomography for staging of esophageal and gastroesophageal malignancy Br J Cancer 78 1998 521-527
20. S. Rankin H. Taylor G. Cook et al. Computed tomography and positron emission tomography in the pre-operative staging of esophageal carcinoma Clin Radiol 53 1998 659-665
21. J.Y. Choi K.H. Lee Y.M. Shim K.S. Lee J.J. Kim S.E. Kim B.T. Kim Improved detection of individual nodal involvment in squamous cell carcinoma of the esophagus by FDG PET J Nucl Med 41 5 2000 808-815
22. R. Mason D. Gold N. Maynard D. Manifold N. Boyle H. Taylor et al. PET scanning for assessing resectability of oesophageal cancer-preliminary results Gut 40 1997 148
23. D. McAteer F. Wallis G. Couper M. Norton A. Welch D. Bruce K. Park M. Nicholson F.J. Gilbert P. Sharp Evaluation of 18F-FDG positron emission tomography in gastric and esophageal carcinoma Br J Radiol 72 1999 525-529
24. T. Lerut P. Flamen N. Ectors E. Van Cutsem M. Peeters M. Hiele W. De Wever W. Coosemans G. Decker P. De Leyn G. Deneffe D. Van Raemdonck L. Mortelmans Histopathologic validation of lymph node staging with FDG-PET scan in cancer of the esophagus and gastroesophageal junction: A prospective study based on primary surgery with extensive lymphadenectomy Ann Surg 232 6 2000 743-752
25. J.V. Räsänen E.I.T. Sihvo M.J. Knuuti H.R.I. Minn M.E.S. Luostarinen P. Laippala T. Viljanen J.A. Salo Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction Ann Surg Oncol 10 8 2003 954-960
26. L.H. Sobin C. Wittekind TNM classification of malignant tumours 5th ed. 1997 Wiley-Liss New York
27. J.R. Beck Likelihood ratios. Another enhancement of sensitivity and specificity Arch Pathol Lab Med 110 1986 685-686
28. R.Y. Chandarwarkar T. Kakegawa H. Fujita et al. Comparative analysis of imaging modalities in the preoperative assessment of nodal metastasis in esophageal cancer J Surg Oncol 561 1996 214-217
29. H. Kato H. Kuwano M. Nakajima T. Miyazaki M. Yoshikawa H. Ojima K. Tsukada N. Oriuchi T. Inoue K. Endo Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma Cancer 94 4 2002 921-928
30. W. Kneist M. Schreckenberger P. Bartestein F. Grünwald K. Oberholzer T. Junginger Positron emission tomography for staging esophageal cancer: Does it lead to a different therapeutic approach? World J Surg 27 2003 1105-1112
31. G.W. Couper D. McAteer F. Wallis M. Norton A. Welch M. Nicolson K.G.M. Park Detection of response to chemotherapy using positron emission tomography in patients with esophageal and gastric cancer Br J Surg 85 1998 1403-1406
32. L.D.M. Brücher Björn W. Weber M. Bauer U. Fink N. Avril H.J. Stein M. Werner F. Zimmerman J.R. Siewert M. Schwaiger Neoadjuvant therapy of esophageal squamous cell carcinoma: Response evaluation by positron emission tomography Ann Surg 233 3 2001 300-309
33. H. Kato H. Kuwano M. Nakajima T. Miyazaki M. Yoshikawa N. Masuda M. Kukuchi R. Manda K. Tsukada N. Oriuchi K. Endo Usefulness of positron emission tomography for assessing the response of neoajuvant chemoradiotherapy in patients with esophageal cancer Am J Surg 184 2002 279-283
34. P. Flamen A. Lerut E. Van Cutsem J.P. Cambier A. Maes W. De Wever M. Peeters P. De Leyn D. Van Raemdonck L. Mortelmans The utility of positron emission tomography for the diagnosis and staging of recurrent esophageal cancer J Thorac Cardiovasc Surg 120 6 2000 1085-1092
35. L.G. Strauss Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients Eur J Nucl Med 23 10 1996 1409-1415